Home - Valeo Pharma

Valeant Canada acquires Valeo Pharma's portfolio

Home - Valeo Pharma

Can scrappy Valeo Pharma (VPH.C) win a Stanley Cup?

Valeo Pharma (VPH.C) president and CEO Steve Saviuk demystifies the value proposition of specialty pharma (Ep 5) First Glance with Jody Vance

Valeo : In an accumulation phase -September 21, 2023 at 02:25 am EDT

Valeo Group's annual shareholders' meetings

TMX TSX

Valeo Pharma Full Year 2022 Earnings: Revenues Beat Expectations, EPS Lags

VALEO PHARMA TO HOST FOURTH QUARTER AND YEAR-END 2023 RESULTS CONFERENCE CALL / WEBCAST - Barron's

SmallCap 60: Valeo Pleased W/ Public & Private Reimbursement Status of Asthma & Blood Thinner Drugs

Sponsors and Exhibitors